| Stage | CR | % of rev | ITT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $755M | 100.00% | $1.5B | 100.00% | ITT ×1.95 |
| Gross profit | $315M | 41.69% | $510M | 34.63% | CR +7.1pp |
| Operating income | $141M | 18.63% | $180M | 12.24% | CR +6.4pp |
| Pre-tax income | $126M | 16.72% | $135M | 9.18% | CR +7.5pp |
| Net income | $97M | 12.89% | $87M | 5.87% | CR +7.0pp |
| Stage | CR | ITT | Gap · A − B |
|---|---|---|---|
| Revenue | $755M100.00% | $1.5B100.00% | ITT ×1.95 |
| Gross profit | 41.69%$315M | 34.63%$510M | CR +7.1pp |
| Operating income | 18.63%$141M | 12.24%$180M | CR +6.4pp |
| Pre-tax income | 16.72%$126M | 9.18%$135M | CR +7.5pp |
| Net income |
| 12.89%$97M |
| 5.87%$87M |
| CR +7.0pp |
None
No disclosed counterparties: CR.